...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> RedHill Biopharma Announces Publication Demonstrating Potential Efficacy of RHB-104 for Crohn’s Disease Associated with MAP Infection
06/23/16
> Morphochem’s Investigational New Drug (IND) Application Accepted by the FDA – Novel Antibacterial for Intravenous Treatment of Clostridium difficile Infections (CDI), MCB3837/MCB3681, Can Now Move into Phase 2
06/22/16
> RedHill Biopharma Announces Positive Final Results with Primary and Secondary Endpoints Met in Phase 1 Study with YELIVA™ in Advanced Solid Tumors
06/22/16
> RedHill Biopharma Announces First Patients Dosed in Phase II Study with BEKINDA™ for IBS-D
06/21/16
> Polyganics Announces CE Mark for NEUROCAP®, the Nerve Capping Device for Treatment and Prevention of Symptomatic Neuroma
06/21/16
> TVM Life Science Ventures VII Announces Investment in Mediti Pharma Inc. for the Development of a Novel Treatment for Alzheimer's Disease Psychosis
06/20/16
> Molecular Breast Cancer Subtyping: Study Confirms Advantages of the In Vitro Diagnostic Test Kit Mammatyper® over Immunohistochemistry (IHC)
06/16/16
> Jörn Aldag Appointed CEO of Hookipa Biotech
06/16/16
> TROD Medical’s Prostate Focal Therapy Device Encage™ Advances in US and UK Clinical Studies
06/16/16
> Sartorius Stedim Biotech Launches Innovative ambr® 250 Modular Bioreactor System
06/15/16
> Biotage Achieves ISO 14001:2004 Certification
06/14/16
> New Sartorius Stedim BioOutsource Microsite Goes Live
06/14/16
> Sartorius Stedim Biotech Presents Virosart® Media
06/13/16
> New Data Shows Agendia’s MammaPrint® can Prevent Under and Over Treatment of Breast Cancer Patients with an Intermediate/Indeterminate OncotypeDx Recurrence Score
06/07/16
> New On-line SPE Cartridges from Biotage
06/07/16
> Fujifilm Diosynth Announces Collaboration on a New 20,000-Liter Microbial Biologics Facility for Use by Its Contract Development and Manufacturing Customers
06/06/16
> Ganymed's IMAB362 Extends Survival in Gastric Cancer
06/05/16
> BioGenes and Eurofins BioPharma Product Testing Munich to Cooperate in the Area of HCP Analysis
06/03/16
> Emperra Partners with the Federal Initiative "German Accelerator Life Sciences" to Expand to US
06/03/16
> Agendia Appoints Dr. Gabriel Hortobagyi as Chairman to their Medical Advisory Board
06/01/16
> Merus N.V. Signs Commercial Multi-Product License for ProBioGen’s GlymaxX® ADCC Enhancement Technology
06/01/16
> ChemConnection and Cristal Therapeutics Announce Successful GMP Production of CriPec® Docetaxel for Phase 1/2a Clinical Trials
06/01/16
> Clinical Study in UK to Evaluate ReGenerCell™ for Diabetic Foot Ulcer Treatment
05/31/16
> Evercyte and VTU Technology Collaborate On Development of Recombinant Media Supplements
05/24/16
> ProBioGen Will License GlymaxX® to Thermo Fisher Scientific for Use in Developing Allergy Diagnostics
05/18/16
> Ganymed to Present Exciting Phase II Clinical Data for IMAB362 in Gastroesophageal Cancer at ASCO 2016 Annual Meeting
05/17/16
> Vetter is a Winner of the AbbVie TRIUMPH AWARD
05/11/16
> LDC and Boehringer Ingelheim Join Forces to Discover a Novel Approach for the Treatment of Schizophrenia
05/11/16
> EMA/CHMP Adopts Positive Opinion for ITM´s EndolucinBeta®
05/10/16
> RedHill Biopharma Announces National Cancer Institute Grant Supporting YELIVA™ Phase II Hepatocellular Carcinoma Study
05/05/16
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 1 of 42